Document is current
Any future updates will be listed below
-
Authors
Kvarta, Mark D. https://orcid.org/0000-0002-1093-1648
Bruce, Heather A.
Chiappelli, Joshua
Hare, Stephanie M.
Goldwaser, Eric L. https://orcid.org/0000-0002-9676-9230
Sewell, Jessica
Sampath, Hemalatha
Lightner, Samantha
Marshall, Wyatt
Hatch, Kathryn
Humphries, Elizabeth
Ament, Seth https://orcid.org/0000-0001-6443-7509
Shuldiner, Alan R.
Mitchell, Braxton D.
McMahon, Francis J. https://orcid.org/0000-0002-9469-305X
Kochunov, Peter
Hong, L. Elliot
- License Information
-
More Information
Article History
Received: 6 October 2020
Revised: 23 March 2021
Accepted: 12 April 2021
First Online: 29 April 2021
Conflict of interest
: L.E.H. has received or plans to receive research funding or consulting fees on research projects from Mitsubishi, Your Energy Systems LLC, Neuralstem, Taisho, Heptares, Pfizer, Luye Pharma, Sound Pharma, Takeda, and Regeneron. A.R.S. is an employee of Regeneron Pharmaceuticals, Inc. and receives compensation for his employment, and is co-inventor of multiple patents. M.D.K. is the co-inventor of a patent pending for the use of GABA-related compounds as fast-acting antidepressants. The remaining authors declare no competing interests.
